EPC, EPO, European Union, Germany, Investment, Litigation, Pharma, Pharmaceutical patent, TRIPS, TRIPs Agreement, UPC

(Rospatt Osten Pross )/ /10 Comments

Since the Eli Lilly v. Canada award of 2017, the relevance of international investment law for patents has been known to a wider public. In response to the revocation of two Canadian patents concerning the compounds olanzapine and atomoxetine by Canadian courts, the US pharmaceutical company Eli Lilly initiated arbitral proceedings against Canada on the…

Germany

(Rospatt Osten Pross) and (Rospatt Osten Pross )/

In its decision of December 15, 2015 the Federal Court of Justice confirmed the judgment of the Karlsruhe Higher Regional Court of 2014 concerning the direct infringement of use patents by manifest arrangement. In this case the defendants had manufactured insulation material made of glass fibres and sold it to the building industry in Germany….